Signal Transducer and Activator of Transcription 1 Is Required for Optimal Foam Cell Formation and Atherosclerotic Lesion Development

Background— Signal transducer and activator of transcription 1 (Stat1) potently regulates gene expression after stimulation by certain cytokines involved in tumorigenesis and host defenses. The present study investigated a novel role for Stat1 in foam cell formation and atherosclerosis. Methods and Results— Inhibition of Stat1 activity by a Stat1-specific DNA “decoy” oligomer transfected into differentiated human THP-1 cells, and deficiency of stat1 in mouse macrophages significantly inhibited foam cell formation assessed by lipid staining and cholesteryl ester accumulation compared with control cells. The mechanism of Stat1 regulation of foam cell formation was uniquely dependent on the scavenger receptor CD36. Blunted Stat1 activity and stat1 deficiency significantly decreased expression of CD36 but not of scavenger receptor-A compared with controls, as assessed by immunoblotting and flow cytometry. Deficiency of CD36 but not scavenger receptor-A in mouse macrophages removed any dependency of foam cell formation on Stat1. In an intraperitoneal model of foam cell formation in which foam cells form in vivo independently of the model ligands used in vitro, stat1 deficiency significantly inhibited foam cell formation and CD36 expression. Transplantation of bone marrow from apolipoprotein e−/−×stat1−/− mice into lethally irradiated, atherosclerosis-susceptible apolipoprotein e−/− recipients significantly reduced both en face aortic lesion coverage and aortic root lesions compared with recipients of bone marrow from genetically matched apolipoprotein e−/− mice. Conclusions— Stat1 regulates CD36 expression and foam cell formation in macrophages in vitro; the Stat1 regulation of foam cell formation requires CD36. The regulation of CD36 expression by Stat1 may be important in other pathophysiological CD36-dependent events. Stat1 deficiency reduces atherosclerosis in an apolipoprotein e−/− atherosclerosis-susceptible bone marrow transplantation model.

[1]  R. Silverstein,et al.  Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o /apoEo mice . , 2007, Atherosclerosis.

[2]  C. Funk Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  E. Tuzcu,et al.  Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). , 2006, The American journal of cardiology.

[4]  Jonathan D. Smith,et al.  Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis Published, JLR Papers in Press, October 7, 2005. , 2006, Journal of Lipid Research.

[5]  K. Moore,et al.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.

[6]  S. Mariotto,et al.  STAT1 as a new molecular target of anti-inflammatory treatment. , 2005, Current medicinal chemistry.

[7]  B. Gao,et al.  Cytokines, STATs and liver disease. , 2005, Cellular & molecular immunology.

[8]  R. Silverstein,et al.  Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ , 2004 .

[10]  G. Sumara,et al.  Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis , 2004, Science.

[11]  P. Shah,et al.  Differential Effects of Green Tea–Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E–Null Mice , 2004, Circulation.

[12]  Deborah A. Corey,et al.  Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[13]  Anastasis Stephanou,et al.  STAT‐1: a novel regulator of apoptosis , 2003, International journal of experimental pathology.

[14]  Scott D Covey,et al.  Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Feldman,et al.  Interleukin-13 Induction of 15-Lipoxygenase Gene Expression Requires p38 Mitogen-Activated Protein Kinase-Mediated Serine 727 Phosphorylation of Stat1 and Stat3 , 2003, Molecular and Cellular Biology.

[16]  S. Yamashita,et al.  Pathophysiology of human genetic CD36 deficiency. , 2003, Trends in cardiovascular medicine.

[17]  N. Sepp,et al.  Adhesion of dendritic cells derived from CD34+ progenitors to resting human dermal microvascular endothelial cells is down‐regulated upon maturation and partially depends on CD11a–CD18, CD11b–CD18 and CD36 , 2002, European journal of immunology.

[18]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[19]  A. Daugherty,et al.  IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[20]  T. Decker,et al.  IFNs and STATs in innate immunity to microorganisms. , 2002, The Journal of clinical investigation.

[21]  Massimo Gadina,et al.  Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway , 2002, Cell.

[22]  Chilakamarti V. Ramana,et al.  Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .

[23]  M. Linton,et al.  Class A scavenger receptors, macrophages, and atherosclerosis , 2001, Current opinion in lipidology.

[24]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[25]  L. Bernier,et al.  Identification of a &ggr;-Interferon-Responsive Element in the Promoter of the Human Macrophage Scavenger Receptor A Gene , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[27]  T. Kodama,et al.  Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  A. Daugherty,et al.  Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice , 2000 .

[29]  J. George,et al.  Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Stark,et al.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.

[31]  D. Steinberg,et al.  The oxidative modification hypothesis of atherogenesis: an overview. , 2000, Free radical biology & medicine.

[32]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[33]  S. Hazen,et al.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.

[34]  E. Coccia,et al.  STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules. , 1999, International immunology.

[35]  S. Hazen,et al.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.

[36]  H. Huynh,et al.  Involvement of insulin-like growth factor-1 and its binding proteins in proliferation and differentiation of murine bone marrow-derived macrophage precursors , 1998, Endocrine.

[37]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[38]  P. Howe,et al.  Oxidized Low Density Lipoprotein and Lysophosphatidylcholine Stimulate Cell Cycle Entry in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[39]  S. Yoshida,et al.  Effects of Interferon-α, β, and γ on the Function of Differentiated Leukemic HL-60 Cells Induced by 1,25-Dihydroxyvitamin D3 , 1996 .

[40]  B. Lehnert,et al.  Granulocyte/macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. , 1995, Journal of immunological methods.

[41]  G. Hoppe,et al.  Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. , 1994, The Journal of clinical investigation.

[42]  P. Grimaldi,et al.  Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.

[43]  J. Darnell,et al.  Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. Akagawa,et al.  Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. , 1988, Journal of immunology.

[45]  Roger A. Davis,et al.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. , 2004, The Journal of clinical investigation.

[46]  G. Stark,et al.  Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. , 2002, Trends in immunology.

[47]  A. Daugherty,et al.  Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. , 2000, The American journal of pathology.

[48]  S. Zuckerman,et al.  Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. , 2000, Journal of lipid research.

[49]  S. Hazen,et al.  Erratum: Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (Journal of Clinical Investigation (2000) 105 (1095-1108)) , 2000 .

[50]  S. Yoshida,et al.  Effects of interferon-alpha, beta, and gamma on the function of differentiated leukemic HL-60 cells induced by 1,25-dihydroxyvitamin D3. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.